Beyond direct killing—novel cellular immunotherapeutic strategies to reshape the tumor microenvironment

The clinical use of cellular immunotherapies is gaining momentum and the number of approved indications is steadily increasing. One class of cellular therapies—chimeric antigen receptor (CAR)-modified T cells—has achieved impressive results in distinct blood cancer indications. These existing cellul...

Descripción completa

Detalles Bibliográficos
Autores principales: Huynh, Duc, Winter, Pia, Märkl, Florian, Endres, Stefan, Kobold, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121530/
https://www.ncbi.nlm.nih.gov/pubmed/36167831
http://dx.doi.org/10.1007/s00281-022-00962-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121530/
https://www.ncbi.nlm.nih.gov/pubmed/36167831
http://dx.doi.org/10.1007/s00281-022-00962-4

Ejemplares similares